Avelumab in Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma[AVENT STUDY]
Clinical trial NCT03439501 · UNKNOWN
Trial details
- NCT number
- NCT03439501
- Sponsor
- Samsung Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-16
- Primary completion
- 2022-01-30
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.